HOME >> MEDICINE >> NEWS
'EuroVacc 02' HIV vaccine trial begins in February 2005

Lausanne, Switzerland and London, United Kingdom, February 16, 2005 -- The European Vaccine Effort against HIV/AIDS, today announced that a phase I clinical trial of novel investigational vaccines comprising DNA-HIV-C and NYVAC-HIV-C for the prevention of HIV infection has started in Lausanne and London in February 2005. These vaccines are based on HIV subtype C, which is prevalent in China, India and sub-Saharan Africa, and constitutes more than 50 percent of the new HIV infections worldwide.

The phase I clinical trial, with the EuroVacc Foundation as the sponsor, will evaluate the safety of DNA-HIV-C alone and of the prime-boost regimen of DNA-HIV-C+NYVAC-HIV-C, and to compare the immunogenicity of the prime-boost regimen to NYVAC-HIV-C alone in healthy volunteers at low risk of acquiring HIV infection. The study will recruit 40 healthy volunteers: 20 at the Centre Hospitalier Universitaire Vaudois (CHUV) in Lausanne, and 20 at St Mary's Hospital, Imperial College London. All volunteers, male or female, should be between 18 and 55 yrs, HIV-negative and at low risk of infection.

The trial will carefully evaluate the safety and immunogenicity of the combination of the vaccines, in particular their ability to generate HIV-specific cell-mediated immune response to HIV, which is considered to be a key determinant of protection against infection. According to the principal clinical investigators Prof. Giuseppe Pantaleo of CHUV in Lausanne and Prof. Jonathan Weber of Imperial College London for the clinical studies, "if this study generates promising results, EuroVacc intends to further evaluate the vaccines in larger clinical trials."

Development background

The vaccine candidates for the trial - DNA-HIV-C and NYVAC-HIV-C - were developed within the network European Vaccine Effort against HIV/AIDS. NYVAC-HIV-C (a vaccine candidate based on poxvirus) was manufactured by sanofi pasteur - the vaccine division of Sanofi-Aventis - a
'"/>

Contact: Tony Stephenson
at.stephenson@imperial.ac.uk
44-207-594-6712
Imperial College London
16-Feb-2005


Page: 1 2

Related medicine news :

1. Pitt marks 50th anniversary of its Salk polio vaccine with reunion, scientific symposium
2. NIAID initiates trial of experimental avian flu vaccine
3. Study finds majority of women willing to accept cervical cancer vaccine for self and children
4. Invasive pneumonia and antibiotic resistance decreased after childhood vaccine introduced
5. Earlier use of prostate cancer vaccines urged by Hopkins scientists
6. Researchers close in on breast cancer vaccine
7. Varicella vaccine effective on chicken pox; Impact on herpes zoster unclear
8. Pathogen-mimicking vaccine as strategy for cancer therapy
9. HIV vaccine trial breaks ground for future research
10. First US kidney cancer vaccine trial underway at Columbia
11. NIAID begins enrolling volunteers for novel HIV vaccine study

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/24/2020)... (PRWEB) , ... January 24, 2020 , ... The new ... days was quickly spread also to impact Thailand, Japan, and South Korea. The virus ... come in contact with live animals that were infected. , EPA has confirmed ...
(Date:1/23/2020)... (PRWEB) , ... January 23, 2020 , ... ... in medical and scientific training, biomedical research, and patient care—today announced the recipients ... Office of Gender Equity in Science and Medicine. The awards aim to mitigate ...
(Date:1/23/2020)... , ... January 23, 2020 , ... Worldwide Business ... Organics Brand Director, Michelle Berger and Vice President of Dairy and Frozen, Jimmy ... Organics is a company that creates organic food and snack options at an affordable ...
(Date:1/23/2020)... ... January 23, 2020 , ... ... memory impairment, has announced the Best Memory Care Facilities in Santa Rosa, California. ... facility features and amenities. , According to the Alzheimer’s Association , ...
(Date:1/23/2020)... , ... January 23, 2020 , ... Park Avenue based ... website jschildhorn.com. Dr. Schildhorn is excited to bring this new digital portal for patient ... Duke and attended medical school at Temple University. With over 12 years of hands-on ...
Breaking Medicine News(10 mins):
(Date:1/28/2020)... ... January 28, 2020 , ... With camaraderie and community ... men overcome addiction. , As a luxury drug and alcohol rehab center, it offers ... case manager to adventure therapy sessions and psychoeducational groups, Calusa is treating the entire ...
(Date:1/28/2020)... ... ... Rachel V. Rose, JD, MBA, a principal with Rachel V. Rose Attorney at ... 3rd Annual Healthcare Compliance Symposium co-hosted by Delaware Law School and First Healthcare ... of healthcare, securities and international law and business throughout her career. Her practice ...
(Date:1/28/2020)... , ... January 28, 2020 , ... Advanced foot ... and ankle wound care for over 20+ years in Livingston County. This medical ... foot and ankle ulcer or wound needs. , Many people are not aware that ...
Breaking Medicine Technology:
Cached News: